​

BriaCell Therapeutics Ownership | Who Owns BriaCell Therapeutics?

OverviewFinancialsChart

BriaCell Therapeutics Ownership Summary

BriaCell Therapeutics is owned by 13.80% institutional investors, 0.61% insiders, and 85.59% retail investors. Rosenberg matthew hamilton is the largest institutional shareholder, holding 0% of BCTX shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.04% of its assets in BriaCell Therapeutics shares.

BCTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBriaCell Therapeutics13.80%0.61%85.59%
SectorHealthcare Stocks 35.75%11.89%52.37%
IndustryBiotech Stocks 36.05%11.82%52.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rosenberg matthew hamilton---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Rosenberg matthew hamilton---

Top Buyers

HolderShares% AssetsChange
Rosenberg matthew hamilton---12.00

Top Sellers

HolderShares% AssetsChange
Rosenberg matthew hamilton---12.00

Sold Out

HolderChange
Rosenberg matthew hamilton-12.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20261416.67%386,7043892.40%1311552.08%7-3-
Dec 31, 202512-9,686-22.06%-79.44%7-41.67%--
Sep 30, 202512-12,427---12---
Mar 31, 20241-50.00%12-96.15%-2110.53%--100.00%--
Dec 31, 20232-312-99.98%-0.00%1---100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index3.23K0.04%3.23K

Recent Insider Transactions

DateNameRoleActivityValue
May 14, 2024Lustig Marc Buy$2.00M
May 14, 2024Lustig Marc Buy$1.91M
Dec 28, 2022Bondarenko Jamieson ChairmanBuy$128.24K
Dec 23, 2022Williams William V. President, CEOBuy$4.91K
Dec 20, 2022Bondarenko Jamieson-Buy$117.70K

Insider Transactions Trends

DateBuySell
2022 Q43-
2022 Q3--
2022 Q1--
2021 Q4--
2021 Q3--

BCTX Ownership FAQ

Who Owns BriaCell Therapeutics?

BriaCell Therapeutics shareholders are primarily institutional investors at 13.80%, followed by 0.61% insiders and 85.59% retail investors. The average institutional ownership in BriaCell Therapeutics's industry, Biotech Stocks , is 36.05%, which BriaCell Therapeutics falls below.

Does Blackrock own BriaCell Therapeutics?

BlackRock is not among the top 10 institutional shareholders of BriaCell Therapeutics.

Who is BriaCell Therapeutics’s biggest shareholder by percentage of total assets invested?

Rosenberg matthew hamilton is BriaCell Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 BriaCell Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of BriaCell Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of BriaCell Therapeutics shares, with 0.04% of its total shares outstanding invested in 3.23K BriaCell Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools